摘要：
2024年11月6日, 北京大学药学院天然药物及仿生药物全国重点实验室PI崔一民教授团队与刘振明研究员团队合作在Advanced Science发表了最新研究成果“Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer Via Regulating PI3K/AKT/NFκB Pathway and Tumor-associated Macrophage”(靶向SLITRK4调节PI3K/AKT/NFκB通路和肿瘤相关巨噬细胞抑制结直肠癌的增殖和肝转移)。
Supporting:
北京大学药学院天然药物及仿生药物全国重点实验室. 北京大学崔一民/刘振明/庞晓丛团队发现结直肠癌肝转移的新靶点并开发新治疗策略[J]. 中国药学(英文版), 2024, 33(12): 1161-1162.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Yimin Cui/Prof. Zhenming Liu/Prof. Xiaocong Pang discovered new targets for liver metastasis in colorectal cancer and developed new treatment strategies[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(12): 1161-1162.
>
>